Dr. Simpson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-418-3376Fax+1 503-494-6968- Is this information wrong?
Education & Training
- Oregon Health & Science UniversityResidency, Dermatology, 1999 - 2002
- Baylor University Medical CenterInternship, Internal Medicine, 1998 - 1999
- University of Texas Southwestern Medical SchoolClass of 1998
Certifications & Licensure
- OR State Medical License 2002 - 2025
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Efalizumab for Moderate to Severe Atopic Dermatitis Start of enrollment: 2005 Jun 01
- Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis Start of enrollment: 2007 Apr 01
- Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regi...Bissonnette, R., Chiesa Fuxench, Z., Kallender, H., Sturm, D., Ren, H., Stein Gold, L., Simpson, E.> ;The Journal of Dermatological Treatment. 2024 Dec 1
- How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users' guide.Kim S Thomas, Laura Howells, Yael A Leshem, Eric L Simpson, Christian Apfelbacher, Phyllis I Spuls, Louise A A Gerbens, Michael E Jacobson, Norito Katoh, Hywel C Willi...> ;The British Journal of Dermatology. 2024 Mar 15
- Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomiz...Simpson, E., Silverberg, J., Worm, M., Honari, G., Masuda, K., Syguła, E., Schuttelaar, M., Mortensen, E., Laws, E., Akinlade, B., Patel, N., Maloney, J., Paleczny, H....> ;Journal of the American Academy of Dermatology. 2024 Feb 1
- Join now to see all
Journal Articles
- Efficacy and Safety of Baricitinib Combined with Topical Corticosteroids for Treatment of Moderate to Severe Atopic DermatitisLawrence F Eichenfield, Eric L Simpson, JAMA Dermatology
- Efficacy and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Eric L Simpson, Hernan Valdez, JAMA Dermatology
- Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their FamiliesJonathan I Silverberg, Amy S Paller, Mark Boguniewicz, Sarah L Chamlin, Eric L Simpson, Lawrence F Eichenfield, Steven R Feldman, Dermatology and Therapy
Authored Content
- Efficacy and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic DermatitisJune 2020
Press Mentions
- Rapid Improvement in Atopic Dermatitis with Topical PDE4 InhibitorMarch 20th, 2023
- New Data Show Promising Results in the Treatment of Atopic Dermatitis on Hands and FeetMarch 19th, 2023
- Dupilumab Improves Hand, Foot Atopic Dermatitis in Phase 3 StudyMarch 19th, 2023
- Join now to see all
Grant Support
- The Role Of The Skin Barrier In Atopic Dermatitis Development And PreventionNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2012
Professional Memberships
- Fellow
Hospital Affiliations
- Portland HCSPortland, Oregon
- OHSU HospitalPortland, Oregon
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: